All lobbying filings

COHERUS BIOSCIENCES, INC.

Lobbying for COHERUS BIOSCIENCES, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $125,000.00 expenses · posted Aug 18, 2025

Official filing document

Lobbying activity 2

Health Issues

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act

Government Issues

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.